Honourable guests officiate at the Forum’s opening ceremony


一眾主禮嘉賓為論壇主持開幕儀式

Professor Li Ping from China Medical University speaks at the Forum


中國醫科大學李萍教授於論壇上演說

Date: 28 Aug 2017 (Monday)

Archive

SCM hosts forum on Quality Research and Standardisation of Chinese Medicines

中醫藥學院舉辦中藥質量研究及標準化論壇

The School of Chinese Medicine (SCM) hosted the Forum on Quality Research and Standardisation of Chinese Medicines, jointly organised by the National Natural Science Foundation of China (NSFC), the Beijing-Hong Kong Academic Exchange Centre and HKBU on 24 and 25 August. A total of 21 experts and scholars from mainland China, Macao and Hong Kong gathered on campus to share their knowledge and insights on major topics concerning the importance of quality research and standardisation of Chinese medicines.

The Forum focused on three themes: basic research, basic and clinical research of proprietary Chinese medicine, and research methodology. The speakers delivered talks with a view to facilitating exchanges and collaboration among academic institutions and research institutes in Hong Kong, Macao and mainland China. They also focused on contributing to the standardisation of Chinese medicines and the development of innovation and technology in order to speed up the advancement of Chinese medicines.

The opening ceremony of the Forum was officiated by Director of Division Ten of the Health Sciences of NSFC Ms Zhang Fengzhu, Deputy Director of the Hong Kong, Macao and Taiwan Affairs Office of NSFC Mr Wang Wenze, Deputy Inspector of the Education, Science and Technology Department of the Liaison Office of the Central People’s Government in the HKSAR Mr Zhang Zongming, Head of the Division of Academic and Training of the Beijing-Hong Kong Academic Exchange Centre Dr Zou Chonghua, President and Vice-Chancellor of HKBU Professor Roland Chin, and Dean of SCM Professor Lyu Aiping.

In his welcoming remarks, Professor Lyu Aiping said that the quality of Chinese medicines was a major concern among both Chinese medicine professionals and the general public. Moreover, despite the increasing popularity of Chinese medicine throughout the world and China’s rapid economic growth, the export of Chinese medicines was rather unsatisfactory. This shortcoming pointed to the lack of competitiveness of Chinese medicine products.

Professor Lyu pointed out that the standardisation and quality control of Chinese medicines were the keys to fostering the development of Chinese medicine and to strengthening its role in the healthcare systems in the country as well as elsewhere in the world.

With China’s implementation on 1 July 2017 of the Chinese Medicine Ordinance, which spells out the significant role and development direction as well as support measures for Chinese medicine, Professor Lyu believed that the thematic discussions at the Forum would further spur research on Chinese medicines.

中醫藥學院於8月24及25日承辦由國家自然科學基金委員會、京港學術交流中心與浸大攜手合辦的中藥質量研究及標準化論壇,邀得21位內地、澳門和香港的專家學者與出席論壇的中藥專家學者和企業代表就不同專題交流分享。

論壇分為基礎研究、中成藥的基礎與臨床研究及研究方法學三個專題,由專家作主題報告,與出席人士深入探討相關課題,旨在集思廣益,促進香港與澳門和內地高校及研究機構的相互交流合作,為中藥標準化和中藥科技創新作出貢獻。

論壇開幕典禮的主禮嘉賓包括國家自然科學基金委員會醫學科學部醫學科學十處張鳳珠處長及港澳台辦公室王文澤副主任、中央政府駐香港特區聯絡辦公室教育科技部副巡視員張總明先生、京港學術交流中心學術與培訓部主任鄒重華博士、浸大校長錢大康教授和中醫藥學院院長呂愛平教授。

呂愛平教授在致歡迎辭時說,中醫藥界和市民大眾都非常關心中藥品質的問題,雖然中醫藥在全世界迅速傳播及內地經濟急速發展,但是中藥出口卻差強人意,反映了中藥產品在國際的競爭力有待提高。他認為中醫藥如要進一步發揚光大,在兩岸三地以至世界各地的醫療體系發揮更大作用,中藥標準化和中藥品質控制是關鍵所在。

呂教授相信內地於今年7月1日實施確立中醫藥地位、發展方針和扶持措施的《中醫藥法》後,為中醫藥奠下更好的發展台階。他期望是次論壇可以進一步促進中藥研究的長足發展。